Argument continues over the best management of women with a first mildly dyskaryotic cervical smear: should they be referred for prompt colposcopy, or should they be kept under cytological review, with recourse to colposcopy if the abnormality persists? One consideration is the amount of anxiety generated. We measured anxiety, retrospectively, in two groups of women who had been managed by one or other method.
INTRODUCTION
That an abnormal cervical smear causes emotional trauma is well recognized. Several groupsl-3 have described the anxiety associatedwith the diagnosisand subsequent management, but none has so far compared the anxiety caused by different management options. This is particularly important in the case of mild dyskaryosis, where there is still much controversy over how patients should be managed. Essentially the options are twofold. The first is to offer all women with a first mildly dyskaryotic smear a prompt microscopic examination of the cervix (colposcopy) and treatment. The second is to arrange for repeat smears to be taken (cytological surveillance) with the proviso that two consecutive normal smears are obtained before the patient is returned to routine follow-up. Any persistent smear abnormality requires colposcopy and treatment. The aim of this study was to show which of the two--cytological surveillance, or prompt colposcopy and treatment-causes more anxiety in women with mildly abnormal cervical smears. review clinic and to complete a questionnaire. The groups comprised women from North Buckinghamshire and from North London, respectively, who were taking part in a comparative study of two management options for mild cervical dyskaryosis", The North Buckinghamshire patients (Stoke Mandeville Hospital and Milton Keynes General Hospital) had been managed according to the Intercollegiate recommendations'', by cytological surveillance with recourse to colposcopy if there was persistence or progression of smear abnormality (cytological surveillance group). These women had all (over the previous 30 months) received standard cytology-laboratory letters informing them of their smear results and what subsequent action had been planned, e.g. a repeat smear due soon, or discharge to routine 3yearly follow-up. The North London patients (early colposcopy group) all had prompt colposcopy and treatment after their first mildly dyskaryotic smear, according to the advice of the local cytology laboratory. These patients had also received a standard cytology-laboratory letter, plus an explanatory leaflet describing the smear result and why a colposcopy examination at the Royal Northern Hospital was indicated. About 30 months after their mildly dyskaryotic entry smear, all patients were invited to attend a colposcopy review clinic. Consequently, both groups had the benefit of colposcopy diagnosis before completing the questionnaire. Given that both groups of patients were aware of their current cervical disease status at the time of completing the questionnaire, it was felt reasonable to ask them to recall previous emotional events following a given smear abnormality over a uniform period of time. ' One pack year is equivalent to smoking 20 cigarettes a day for 12 months 258 Strict entry requirements had been defined for the main comparative study", and for these patients detailed clinical histories were available. For the purpose of the anxiety arm of the study, however, less stringent entry requirements were employed (e.g. the patient did not need to be residing in the original catchment area at the time of the study). Thus, 345 patients attended the review clinic to complete a questionnaire-163 cytology-surveillance patients and 182 early-colposcopy patients. Anxiety was measured with a selfassessment system wherein the patient marked her answer to the question 'How much anxiety did you experience?' on a 100 mm visual analogue scale labelled on the left 'No anxiety' and on the right 'Most severe anxiety imaginable'. These anxiety questions referred specifically to the points made on standard cytology follow-up letters, or in colposcopy-clinic invitation letters sent to the patients. For example, question 1 asked about the anxiety of knowing that the smear was abnormal whilst question 2 asked about the anxiety of needing a repeat smear in 6 months. Question 3 enquired about anxiety experienced while waiting for the result of the second smear and question 4 about the anxiety of discovering that the repeat smear was still abnormal. Question 5 referred to the anxiety of being sent a colposcopy appointment and question 6 asked about the anxiety of being sent the colposcopy research clinic appointment. In addition, a question about the anxiety of a dental appointment was included.
As well as the questions about anxiety, more specific questions were included-for instance, about fear of cancer, resentment of partner, and loss of libido. Finally, we asked the patient which management option would she have preferred after her first mildly abnormal smear. The content of the questions was assessed by a clinical psychologist and it was considered that, despite their simplicity, a valid comparison could be made between the two groups of patients, particularly if a large difference in response emerged. All patients in both groups attended the review colposcopy clinic and were invited to complete the questionnaire after their colposcopy examination and assessment. Table 1 shows the clinical features of the two populations originally studied in the main comparative study" (i.e. those who met the stringent entry requirements for that study). Just under one-third of the cytological surveillance group patients had already had colposcopy as a result of persistent smear abnormality during the 3D-month study period, and were therefore not invited to the colposcopy review clinic. Table 2 shows the anxiety score when mild dyskaryosis was first diagnosed and during subsequent management. All 182 early-colposcopy group patients had been referred for colposcopy after their first mildly dyskaryotic smear and 117 of these had had a previous smear abnormality not amounting to mild dyskaryosiS. In contrast, all the patients in the cytology-surveillance group had been kept under cytological follow-up (despite a mildly dyskaryotic smear) rather than having prompt referral for colposcopy. A high anxiety score was recorded at the diagnosis of a smear abnormality in both groups (59.5 and 64.2). Anxiety was considerably less when a woman was asked to attend for a repeat smear in 6 months time. A similar level of anxiety persisted when the result was awaited. If the smear continued to be abnormal, there was a further increase in anxiety (59.5 and 66.3). The colposcopy appointment itself also caused high anxiety. By contrast, the invitation to the review colposcopy clinic produced only modest anxiety, although considerably more than a visit to the dentist.
RESULTS
More results from the questionnaire are shown in Table  3 . When told that the smear was mildly abnormal 33% and 47% believed that they had cancer. The percentage was significantly higher in the group who were managed by immediate colposcopy (+14%, CI +3 to +24). The diagnosis also resulted in a loss of interest in sexual intercourse (in 18% and 32%, respectively), and resentment of the partner in 7% and 17% of women, respectively. Again the percentages are substantially higher in the colposcopy group (+14 CI +5 to +24% and 10%, CI +3% to +18).
Although the invitation to attend for colposcopy resulted in high anxiety, patients expressed greater satisfaction with immediate colposcopy than with cytological surveillance: and both groups preferred the option of immediate colposcopy. Table 4 examines the effect of the patients' belief that they have cancer when told that the smear is abnormal. At all stages of management, the anxiety score was higher in patients who believed they had cancer (irrespective of group).
DISCUSSION
In this survey the appointment for colposcopy and treatment caused significantly more acute anxiety than the request for a repeat smear. The difference in anxiety between the two groups cannot be explained by differences in the clinical variables but it is possible that linguistic difficulties related to the ethnic composition might be a contributing factor. Those who have colposcopy are more likely to fear cancer, resent their partners, and lose their libido than women managed by cytological surveillance. Indeed cancer fear may be the reason why a high proportion of early colposcopy patients are anxious'', However, a persistent smear abnormality is also a source of great anxiety. This anxiety is maintained when the patient receives an appointment for the colposcopy clinic. Anxiety is particularly severe in those women who acknowledged that they believed that they had cancer, and this additional anxiety was not dispelled during their subsequent management.
The 345 women who took part in the study were invited to give written comments. Only 22 (i.e, 6%) complained that they had insufficient information. Thus it is clearly not sufficient to give the patient an 'opportunity' to ask questions: it is the doctor's responsibility to make clear to the patient that an abnormal smear is not cancer. This is particularly important for those women managed by immediate colposcopy: the invitation to attend for this investigation generates a score equivalent to 63% of the worst anxiety imaginable. 
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An unexpected finding was the greater satisfaction expressed by patients who were managed by immediate colposcopy. This may be attributable to the relief experienced when a histological diagnosis is made following the extreme anxiety associated with the colposcopy examination itself. Perhaps patients who have undergone colposcopy feel reassured that their disease has at last been treated.
As regards the controversy concerning colposcopy versus cytological surveillance, this study suggests that (from the anxiety point of view) the patient is better managed by cytological surveillance. This option, however, carries the risk that some women will have persistent smear abnormality resulting in high levels of anxiety, especially when the invitation for referral colposcopy arrives. These patients require special attention and doctors who undertake cervical screening ought to explain carefully the purpose of the smear test and its interpretation.
